TNF inhibitor
Date |
Type | Title | Save |
|---|---|---|---|
| 17 May 2017 | News | Inflammatory Arthritis Stable after Switch to Biosimilar Infliximab | |
| 16 May 2017 | News | NOR-SWITCH Study Validates Biosimilar Use in Multiple Indications | |
| 15 May 2017 | Slide of the day | New TNF Inhibitor Biosimilars | |
| 24 Apr 2017 | News | FDA Approves Renflexis as Second Infliximab Biosimilar | |
| 24 Mar 2017 | Social | RT @DanielHSolomon: MI Risk 39% Lower for Patients With RA Taking TNF Inhibitors https://t.co/7ihHmdNPNy via @medscape | |
| 24 Mar 2017 | Social | Amgens Amjevita (biosimilar of Humira) was approved by EMA for EU use in adult/Peds arthritis IBD, SpA & more https://t.co/O7JBrvtZgE | |
| 23 Mar 2017 | Social | 4 center study of 23 HIV pts shows TNF inhibitors are not assoc w/ higher rates of serious infxn in HIV pts https://t.co/D9R0LByBIJ | |
| 15 Mar 2017 | Social | 1241 PsA TNFi initiations - Persistence predictors include TNFi naive, more skin, prior DMARDs, Mod/High Dz activity https://t.co/WnFj6WtS33 | |
| 10 Mar 2017 | Social | 2015 study of 4504 IBD pts shows TNFi use has 2 fold risk of central demyelinating Dz, w/ absolute risk 3.9/10000 PY https://t.co/v0MMvasUic | |
| 09 Mar 2017 | Social | Analysis of FDA FAERS database shows TNF inhibitor ISRs are lower in pts >70yrs & lower when TNFi combined w/ MTX https://t.co/B4t6ivsQDG | |
| 08 Mar 2017 | Social | Case and Review- Etanercept and other TNFi can be safely used to treat HIV positive patients. https://t.co/Ak0YE8XuuO | |
| 04 Mar 2017 | Social | RT @ACRheum: #Biosimilars: What Do Patients Need to Know? Read the Q&A blog post from @AngusWorthing & @ACRSimpleTasks → https://t.co/GP9wC… | |
| 03 Mar 2017 | Social | RT @USBiosimilars: #AAD2017 Surveyed physicians lack understanding of interchangeability. #Biosimilars Forum has info on this concept. http… | |
| 17 Feb 2017 | Social | New Bluetooth device and App to monitor the temperature of your biologic therapy. KEEP IT OUT OF THE VEGGIE CRISPER https://t.co/yghCLkUFIq | |
| 17 Feb 2017 | Social | RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg https://t.co/bBAaUWHGt1 | |
| 15 Feb 2017 | Social | RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg https://t.co/bBAaUWHGt1 | |
| 03 Feb 2017 | Social | infliximab 4 wks before TKA or THA did not increase risk of infection https://t.co/0PPLyNnNP5 @CCalabreseDO @HealioRheum @medpagetoday | |
| 31 Jan 2017 | News | Is the Jury Still Out on Triple Therapy vs. MTX + TNF inhibitor? | |
| 24 Jan 2017 | Social | Janssen has applied to FDA for new indications (AS, PsA) for golimumab based on GO-ALIVE, GO-VIBRANT trials https://t.co/qTZMJtWmya | |
| 12 Jan 2017 | Social | ARTIS #RA registry shows those initiating TNFi within 3 yrs of onset, double their odds of returning to work. https://t.co/WytSlSYRj1 |
